Dr. Mazhar Elamir, MD
Pulmonologist | Pulmonary Disease
192 Harrison Avenue Jersey City NJ, 07304About
Mazhar E. Elamir, MD, FCCP, is an internist, pulmonologist, and sleep medicine physician who diagnoses and treats patients at MM Jersey City Breathing Center with three office locations in Jersey City, NJ. Furthermore, he is affiliated with Christ Hospital and Bayonne Medical Center (Care Point Health) and Jersey City Medical Center (JJW Barnabas Health) in Jersey City, NJ. As a pulmonologist, he specializes in the management of diseases involving the respiratory tract. Dr. El Amir has an impressive professional journey that spans more than thirty years. Disorders treated include asthma, COPD, sleep apnea, bronchitis, insomnia, narcolepsy, cholesterol, sleep disorders, restless leg syndrome, primary care, preventive medicine, immunizations, diabetes, hypertension, arthritis, back pain, heart disease, and obesity.
Education and Training
Cairo University, Faculty of Medicine, Qasr Al-Ainy MD 1981
Board Certification
American Board of Internal Medicine
Provider Details
Areas of expertise and specialization
Treatments
- Asthma
- Back Pain
- Pain
- Peripheral Artery Disease (pad)
- Vascular Disease
Professional Memberships
- Fellow of the American College of Chest Physicians
Fellowships
- Interfaith Medical Center Pulmonary Medicine
Dr. Mazhar Elamir, MD's Practice location
Dr. Mazhar Elamir, MD's reviews
Write ReviewRecommended Articles
- 7 Tips on Living with Asthma
Asthma is a chronic lung disorder that causes inflammation in the air passage leading to the lungs, making it incredibly difficult to breath. Common symptoms include Shortness of breath, Wheezing, a tight feeling in the chest and Coughing. Asthma can be either Innate (since childhood) or caused by...
- Vlogger with Cystic Fibrosis Tells It Like It Is
Charles Michael Duke is a 22-year-old video blogger who blogs on YouTube about living with cystic fibrosis. He's always singing or joking about his life, and posts comedic videos about his experience living with cystic fibrosis.A talented musician and actor, Charles has even created his own song...
- FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis
Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...
- New, Promising Cystic Fibrosis Drug Needs Funding
Canada has the highest rate of cystic fibrosis in the entire world, with approximately 1 in 134 citizens suffering from the disease. However, a recent drug that has been found to be "life changing" for some cystic fibrosis patients is not being funded.Official responseHealth Minister Adrian Dix...
- What Could Happen if My Pneumonia Remains Untreated?
There are several types of pneumonia that vary in their degree of seriousness. Pneumonia caused by a viral infection can make people feel very sick with fever, cough, and tiredness. However, viral pneumonia tends to go away on its own after some time. A "walking pneumonia" is a mild case of...
- Groundbreaking Triple-Therapy Could Be on the Horizon for Cystic Fibrosis
Researchers work around the clock and the world to find new discoveries in terms of cystic fibrosis treatment. Thanks to foundations, donations, and ongoing research, cystic fibrosis has made leaps and bounds as far as treatment is concerned. There is one pharmaceutical company at the forefront of...